| 000 | 01711 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516095335.0 | ||
| 264 | 0 | _c20130104 | |
| 008 | 201301s 0 0 eng d | ||
| 022 | _a1744-5078 | ||
| 024 | 7 |
_a10.3109/09273948.2012.670359 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMorshedi, R Grant | |
| 245 | 0 | 0 |
_aBilateral acute iris transillumination following systemic moxifloxacin for respiratory illness: report of two cases and review of the literature. _h[electronic resource] |
| 260 |
_bOcular immunology and inflammation _cAug 2012 |
||
| 300 |
_a266-72 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Infective Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAza Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluoroquinolones |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIris Diseases _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMoxifloxacin |
| 650 | 0 | 4 |
_aOcular Hypertension _xdrug therapy |
| 650 | 0 | 4 |
_aPigment Epithelium of Eye _xdrug effects |
| 650 | 0 | 4 |
_aQuinolines _xadministration & dosage |
| 650 | 0 | 4 |
_aRespiratory Tract Infections _xcomplications |
| 650 | 0 | 4 |
_aTrabecular Meshwork _xdrug effects |
| 650 | 0 | 4 |
_aTransillumination _xmethods |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBettis, Daniel I | |
| 700 | 1 | _aMoshirfar, Majid | |
| 700 | 1 | _aVitale, Albert T | |
| 773 | 0 |
_tOcular immunology and inflammation _gvol. 20 _gno. 4 _gp. 266-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/09273948.2012.670359 _zAvailable from publisher's website |
| 999 |
_c21861384 _d21861384 |
||